Cargando…

Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system

Accurate and precise point-of-care (POC) testing for C-reactive protein (CRP) can help support healthcare providers in the clinical management of patients. Here, we compared the analytical performance of 17 commercially available POC CRP tests to enable more decentralized use of the tool. The follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Calarco, Serafina, Fernandez-Carballo, B. Leticia, Keller, Thomas, Weber, Stephan, Jakobi, Meike, Marsall, Patrick, Schneiderhan-Marra, Nicole, Dittrich, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858008/
https://www.ncbi.nlm.nih.gov/pubmed/36662693
http://dx.doi.org/10.1371/journal.pone.0267516
_version_ 1784873991590117376
author Calarco, Serafina
Fernandez-Carballo, B. Leticia
Keller, Thomas
Weber, Stephan
Jakobi, Meike
Marsall, Patrick
Schneiderhan-Marra, Nicole
Dittrich, Sabine
author_facet Calarco, Serafina
Fernandez-Carballo, B. Leticia
Keller, Thomas
Weber, Stephan
Jakobi, Meike
Marsall, Patrick
Schneiderhan-Marra, Nicole
Dittrich, Sabine
author_sort Calarco, Serafina
collection PubMed
description Accurate and precise point-of-care (POC) testing for C-reactive protein (CRP) can help support healthcare providers in the clinical management of patients. Here, we compared the analytical performance of 17 commercially available POC CRP tests to enable more decentralized use of the tool. The following CRP tests were evaluated. Eight quantitative tests: QuikRead go (Aidian), INCLIX (Sugentech), Spinit (Biosurfit), LS4000 (Lansionbio), GS 1200 (Gensure Biotech), Standard F200 (SD Biosensor), Epithod 616 (DxGen), IFP-3000 (Xincheng Biological); and nine semi-quantitative tests: Actim CRP (ACTIM), NADAL Dipstick (nal von minden), NADAL cassette (nal von minden), ALLTEST Dipstick (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10-40-80 (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10–30 (Hangzhou Alltest Biotech), Biotest (Hangzhou Biotest Biotech), BTNX Quad Line (BTNX), BTNX Tri Line (BTNX). Stored samples (n = 660) had previously been tested for CRP using Cobas 8000 Modular analyzer (Roche Diagnostics International AG, Rotkreuz, Switzerland (reference standards). CRP values represented the clinically relevant range (10–100 mg/L) and were grouped into four categories (<10 mg/L, 10–40 mg/L or 10–30 mg/L, 40–80 mg/L or 30–80 mg/L, and > 80mg/L) for majority of the semi-quantitative tests. Among the eight quantitative POC tests evaluated, QuikRead go and Spinit exhibited better agreement with the reference method, showing slopes of 0.963 and 0.921, respectively. Semi-quantitative tests with the four categories showed a poor percentage agreement for the intermediate categories and higher percentage agreement for the lower and upper limit categories. Analytical performance varied considerably for the semi-quantitative tests, especially among the different categories of CRP values. Our findings suggest that quantitative tests might represent the best choice for a variety of use cases, as they can be used across a broad range of CRP categories.
format Online
Article
Text
id pubmed-9858008
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-98580082023-01-21 Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system Calarco, Serafina Fernandez-Carballo, B. Leticia Keller, Thomas Weber, Stephan Jakobi, Meike Marsall, Patrick Schneiderhan-Marra, Nicole Dittrich, Sabine PLoS One Research Article Accurate and precise point-of-care (POC) testing for C-reactive protein (CRP) can help support healthcare providers in the clinical management of patients. Here, we compared the analytical performance of 17 commercially available POC CRP tests to enable more decentralized use of the tool. The following CRP tests were evaluated. Eight quantitative tests: QuikRead go (Aidian), INCLIX (Sugentech), Spinit (Biosurfit), LS4000 (Lansionbio), GS 1200 (Gensure Biotech), Standard F200 (SD Biosensor), Epithod 616 (DxGen), IFP-3000 (Xincheng Biological); and nine semi-quantitative tests: Actim CRP (ACTIM), NADAL Dipstick (nal von minden), NADAL cassette (nal von minden), ALLTEST Dipstick (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10-40-80 (Hangzhou Alltest Biotech), ALLTEST Cassette cut-off 10–30 (Hangzhou Alltest Biotech), Biotest (Hangzhou Biotest Biotech), BTNX Quad Line (BTNX), BTNX Tri Line (BTNX). Stored samples (n = 660) had previously been tested for CRP using Cobas 8000 Modular analyzer (Roche Diagnostics International AG, Rotkreuz, Switzerland (reference standards). CRP values represented the clinically relevant range (10–100 mg/L) and were grouped into four categories (<10 mg/L, 10–40 mg/L or 10–30 mg/L, 40–80 mg/L or 30–80 mg/L, and > 80mg/L) for majority of the semi-quantitative tests. Among the eight quantitative POC tests evaluated, QuikRead go and Spinit exhibited better agreement with the reference method, showing slopes of 0.963 and 0.921, respectively. Semi-quantitative tests with the four categories showed a poor percentage agreement for the intermediate categories and higher percentage agreement for the lower and upper limit categories. Analytical performance varied considerably for the semi-quantitative tests, especially among the different categories of CRP values. Our findings suggest that quantitative tests might represent the best choice for a variety of use cases, as they can be used across a broad range of CRP categories. Public Library of Science 2023-01-20 /pmc/articles/PMC9858008/ /pubmed/36662693 http://dx.doi.org/10.1371/journal.pone.0267516 Text en © 2023 Calarco et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Calarco, Serafina
Fernandez-Carballo, B. Leticia
Keller, Thomas
Weber, Stephan
Jakobi, Meike
Marsall, Patrick
Schneiderhan-Marra, Nicole
Dittrich, Sabine
Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
title Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
title_full Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
title_fullStr Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
title_full_unstemmed Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
title_short Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
title_sort analytical performance of 17 commercially available point-of-care tests for crp to support patient management at lower levels of the health system
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858008/
https://www.ncbi.nlm.nih.gov/pubmed/36662693
http://dx.doi.org/10.1371/journal.pone.0267516
work_keys_str_mv AT calarcoserafina analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem
AT fernandezcarballobleticia analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem
AT kellerthomas analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem
AT weberstephan analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem
AT jakobimeike analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem
AT marsallpatrick analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem
AT schneiderhanmarranicole analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem
AT dittrichsabine analyticalperformanceof17commerciallyavailablepointofcaretestsforcrptosupportpatientmanagementatlowerlevelsofthehealthsystem